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Histone modifications associated with HMTs <p>Mass spectrometry analysis of the post-transcriptional modifications of histones H3 and H4 that were co-purified with histone meth- yltransferases Suv39h1 and G9a shows that, in HeLa cells, histone methyltransferases can be physically associated with acetylated histones,  which normally mark transcriptionally active chromatin.</p>
Abstract
Specific combinations of post-translational modifications of histones alter chromatin structure,
facilitating gene transcription or silencing. Here we have investigated the 'histone code' associated
with the histone methyltransferases Suv39h1 and G9a by combining double immunopurification and
mass spectrometry. Our results confirm the previously reported histone modifications associated
with Suv39h1 and G9a. Moreover, this method allowed us to demonstrate for the first time an
association of acetylated histones with the repressor proteins Suv39h1 and G9a.
Background
The amino-terminal tails of nucleosomal histones protrude
from the DNA and are subject to covalent modifications.
These modifications include lysine acetylation, lysine and
arginine methylation, serine and threonine phosphorylation,
ADP-ribosylation, and ubiquitination [1]. Histone lysine
methylation can have different effects depending on the resi-
due that is modified: methylation of histone H3 at Lys4
(H3K4) is associated with gene activation, whereas methyla-
tion of H3K9, H3K27, and H4K20 generally correlates with
transcriptional repression [2-4]. The roles of H3K36 and
H3K79 methylation remain elusive; indeed, these modifica-
tions are associated with both transcriptional activation and
repression [5,6].
Lysine residues can be mono-, di-, or trimethylated, inducing
different biological responses [3,7,8]. Thus, for example,
highly condensed heterochromatic regions show a high
degree of trimethylated H3K9 (H3K9me3), whereas euchro-
matic regions are preferentially enriched in mono- and
dimethylated H3K9 [2,3]. Histone lysine methylation is
mediated by histone methyltransferases (HMTs), many of
which contain a conserved SET [Su(var)3-9, Enhancer-of-
zeste, Trithorax] domain, such as Suv39h1 (Suppressor of
variegation 39h1) and G9a [1,2,9]. Suv39h1 belongs to a fam-
ily of peri-centromeric proteins and is responsible for H3K9
trimethylation [10-13]. G9a (EuHMTase-2) is the major
methylase responsible for mono- and dimethylation of H3K9
in euchromatic regions [14,15], but it may also be present in
heterochomatic regions [16].
Covalent modifications of histones can regulate gene expres-
sion directly or through recruitment of non-histone effector
proteins [2,17]. These effector proteins bind modified chro-
matin using a variety of chromatin-binding domains. For
example, bromodomains recognize acetylated lysines,
whereas chromo, MBT, Tudor, W40 domains and PHD fin-
gers, recognize methylated lysines [17,18]. Repressive
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methyl-lysine modifications are recognized by chromodo-
main-containing proteins such as HP1 and Polycomb (PcG),
which bind methylated H3K9 and H3K27, respectively, and
contribute to creation of heterochromatin-like structures
[19]. Thus, H3K9 methylation has been linked to both DNA
methylation [20,21] and X-chromosome inactivation [22].
Different modifications of histone amino-terminal tails con-
stitute the so-called 'histone code' [23]. Indeed, specific com-
binations of histone modifications can alter chromatin
structure to allow transcription or to repress it, either revers-
ibly or stably [1]. Chromatin modifications confer a unique
identity on the nucleosomes involved. The composite pattern
of modifications regulates the binding and activities of other
chromatin-associated components. Indeed, modifications of
histones at a specific nucleosome very likely influence subse-
quent modifications, regulated by both cis and trans mecha-
nisms. Characterizing such modifications could provide
insight into the roles of chromatin-binding proteins
In this study, we were interested in the 'histone code' associ-
ated with the HMTs Suv39h1 and G9a, as these two HMTs
generally localize to two distinct regions in the nucleus. Stud-
ying modifications of the histones associated with these
HMTs could help in understanding the in vivo state of consti-
tutive heterochromatin associated with Suv39h1, and that of
the silent euchromatin and facultative heterochromatin asso-
ciated with G9a.
Our approach was to identify post-translational modifica-
tions on histones co-purified with tagged Suv39h1 and G9a
HMTs. We performed a double immunopurification of these
proteins from chromatin preparations enriched in mono-
nucleosomes. We then studied histone modifications by a
propionylation-based modification method, followed by mass
spectrometry analysis [24-27].
We used four cell systems in this study: normal liver cells,
HeLa cells, HeLa cells expressing a tagged form of Suv39h1,
and HeLa cells expressing a tagged form of G9a. We began by
comparing the global epigenetic modifications of crude nucle-
osomal histones isolated from these cell lines. We observed a
decrease of the three repressive trimethylation marks (H3K9,
H3K27 and H4K20) in cancerous HeLa cells compared with
normal liver cells. HeLa cells expressing tagged Suv39h1 have
a higher H3K9me3 content than the parent HeLa cells,
whereas HeLa cells expressing tagged G9a show a higher level
of H3K9me and non-modified H3K9. We also identified a
new epigenetic modification, the monomethylation of Lys79
on histone H4. Our results help define the histone code asso-
ciated with Suv39h1 and G9a. Histone H3 associated with
Suv39h1 is heavily trimethylated at Lys9, whereas H3K27 and
H4K20 are mainly dimethylated. In addition, Suv39h1 is
associated with methylation at H3K18, H3K79 and H4K79.
Histone H3 associated with G9a is mainly mono- or dimeth-
ylated at Lys9, as expected. Interestingly, we find Suv39h1
and G9a to be associated with substantial acetylation of
H4K16, H3K18 and H3K23.
Taken together, our results confirm some histone modifica-
tions previously found to be associated with Suv39h1 and
G9a, and show, for the first time, an unexpected association
between these repressor proteins and histone acetylation,
which normally activates transcription.
Results
Determination of global histone modifications
We first compared the basal modifications present on the
crude nucleosomal histones in the different cell lines used:
the cancerous HeLa cell line, and the HeLa cell lines stably
expressing the H3K9-specific trimethylase Suv39h1 (HeLa-
Suv39h1) or dimethylase G9a (HeLa-G9a).
HeLa-Suv39h1 and HeLa-G9a cell lines give a different back-
ground pattern of H3K9, H3K20 and H3K27 methylation
states. Indeed, our results show an approximately 40%
increase in H3K9me3 in HeLa-Suv39h1 cells compared to
HeLa cells (Figure 1b), whereas levels of this modification are
similar in HeLa and HeLa-G9a cells (Figure 1b). In HeLa-
Suv39h1 cells, H4K20me3 and H3K27me3 are present at
similar levels to those found in HeLa cells (Figure 1b). When
w e  c o m p a r e  H e L a - S u v 3 9 h 1  t o  HeLa cells, the increase in
H3K27me2 is similar to the decrease in H3K27me, by approx-
imately 10-15% (Figure 1b), whereas H3K27me3 increases
slightly in HeLa-G9a cells (Figure 1b). Surprisingly, in HeLa
cells expressing the H3K9 dimethylase G9a, the H3K9me and
non-modified H3K9 (H3K9nm) forms increase significantly,
whereas H3K9me2 decreases by 21% relative to HeLa cells
(Figure 1b). Generally, methylation at H3K27 and H4K20
occurs to the same extent in HeLa and in HeLa-G9a cells (Fig-
ure 1b). Methylation on H3K36 occurs at comparable levels in
HeLa cells and in HeLa-Suv39h1 cells, whereas HeLa-G9a
cells show a slight increase (15%) in non-modified H3K36
(Figure 1b). In HeLa-G9a cells, H3K36me2 decreases by
roughly 18% compared with HeLa cells (Figure 1b).
For the amino-terminal histone H4 peptide 4-
GK5GGK8GLGK12GGAK16R-17 ('peptide 4-17'), the predomi-
nant form detected in the three cell lines was a non-modified
one corresponding to an ion of 1,550 m/z (Figure 1c). The
most abundant single modification of this peptide is
acetylated H4K16 (H4K16ac), detected as an ion of 1,536 m/
z, which appears at a level of 14% in HeLa cells, 15% in HeLa-
Suv39h1, and 6% in HeLa-G9a cells (Figure 1c). H4K16ac is
found mostly alone, but can be found in combination with
H4K8ac or with H4K12ac (data not shown). A triacetylated
form of this peptide was also found, representing less than 1%
of the total (data not shown). The second most abundant
modification of peptide 4-17 is H4K12ac, which is found
either as a single modification or in combination with
H4K8ac or H4K16ac (Figure 1c, panacetyl). Considering thehttp://genomebiology.com/2007/8/12/R270 2007,     Volume 8, Issue 12, Article R270       Robin  R270.3
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Comparison of histone H3 and H4 modifications in different cell types Figure 1
Comparison of histone H3 and H4 modifications in different cell types. (a) Purification of crude nucleosomal histones. Nucleosomal histones were 
separated on a 4-12% gradient NuPAGE gel and run in MES buffer (Invitrogen), fixed, and stained with Seeblue (Invitrogen). Lane 1, SeeBlue pre-stained 
molecular weight markers (Invitrogen); lane 2, nucleosomal histones from normal mouse liver; lane 3, nucleosomal histones from HeLa cells, purified on a 
POROS HQ column. (b) Methylation states of H3K9, H3K27, H3K36, and H4K20. nm, non-modified; me, monomethyl; me2, dimethyl; me3, trimethyl. 
Shown are the means of four independent experiments. (c) Basal amino-terminal modifications of histone 4 in the indicated cell types. 'H4 4-17nm': 
unmodified H4 peptide containing amino acids 4-17. Shown are the means of four independent experiments (± standard deviation). Pan-ac: panacetylated.
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total monoacetylated plus panacetylated peptide, H4K12ac
occurs in 5% of the peptide 4-17 in HeLa cells, 10% in Hela-
Suv39h1, and less than 1% in HeLa-G9a cells. We cannot
explain the much lower level observed in HeLa-G9a cells.
Finally, we found a new modification on histone H4: H4K79
monomethylation (see Additional data file 2). Indeed,
approximately 20% of H4K79 is methylated in HeLa, HeLa-
Suv39h1, HeLa-G9a, and normal liver cells. We confirmed
this methylation by analyzing trypsin-digested histone H4
without any additional treatment. Using this method, this ion
gives a poor signal, and it is detected at a level of 2% of the
partially digested K79-R92 peptide. This ten-fold decrease is
mostly due to the poor signal, but this ion gives a robust and
complete y-series and a poor b-series in the collision frag-
mentation result. This modification has never been described
in mammals but was suggested in Physarum [28]. We also
detected an acetylated form of this amino acid at a level of 6%
in the background cell lines.
To further validate our method, we compared the global his-
tone modifications in normal liver cells and in the cancerous
HeLa cells. This approach has been validated in previous
studies of histone modifications in cancer cells [29]. Our
results show a dramatic difference in the usage of the histone
H3 variant H3.3, which, surprisingly, is present in 60% of the
nucleosomes of normal mouse liver and in only 2-3% of
nucleosomes in HeLa cell lines (data not shown). The
amounts of the histone H2A variant macro-H2A seem com-
parable in normal liver cells and HeLa cells (Figure 1a).
We then extensively studied the three lysine methylation
modifications associated with heterochromatin - H3K9me,
H4K20me and H3K27me - as well as the H3K36me modifica-
tion. We observed a decrease of 10-20% for the repressive tri-
methylation of H3K9, H3K27 and H4K20 in HeLa cells
compared to normal liver cells (Figure 1b). A similar result
has already been reported for H4K20 [29]. Conversely, the di-
and trimethylated lysine H3K36, which are mainly associated
with transcriptional activation, show an increase in HeLa
cells (Figure 1b), whereas the non-modified H3K36 decreases
significantly in HeLa cells compared to normal liver cells
(Figure 1b).
For the amino-terminal histone H4 peptide 4-17, we also
detected three different ions. The non-modified form is the
predominant species in both normal liver and in HeLa cells
(Figure 1c). A single acetylation at H4K16 (H4K16ac)
accounts for 23% of the peptide 4-17 in liver and 14% in HeLa
cells (Figure 1c). This H4K16ac modification can be found in
combination with H4K8ac or with H4K12ac in another 7% of
the peptide 4-17 species in mouse liver cells (data not shown).
Considering the total monoacetylated plus panacetylated
peptides, H4K12ac occurs 10% of the time in normal liver but
only 5% in HeLa cells (Figure 1c and data not shown).
In summary, the protocol we used to study modifications of
crude histone preparations, especially those of histones H3
and H4, gave satisfactory and informative results. Conse-
quently, we used this protocol to study the histone code asso-
ciated with the HMTs Suv39h1 and G9a.
Determination of the epigenetic modifications on 
histones H3 and H4 associated with HMTs Suv39h1 and 
G9a in HeLa cells
The main goal of our study was to identify the histone modi-
fications associated with the H3K9-specific HMTs Suv39h1
and G9a, especially on histones H3 and H4. To this end, we
performed double-affinity purification of HA-Flag-Suv39h1
and HA-Flag-G9a complexes from chromatin enriched in
mononucleosomes (Figure 2a and Additional data file 1). The
Suv39h1-associated complex is visualized in Figure 2b, lane 2.
We observe good stoichiometry of the Suv39h1-associated
proteins strongly bound to chromatin, such as members of
the HP1 protein family, histones H1-H5, and macro-H2A
(Figure 2b). The double immunopurification has been per-
formed on chromatin extracts from the HeLa control cell line
transduced by the empty vector to measure the background
signal. The results do not give any quantifiable signal, espe-
cially at the histone molecular weight (data not shown).
H3K9me3 and H4K20me2 associate with Suv39h1 at levels of
81% and 68%, respectively (Figure 2c). These percentages are
approximately 40% lower in HeLa-Suv39h1 cells (compare
Figures 1b and 2b, or see Additional data file 3). Position
H3K27 is dimethylated (H3K27me2) 80% of the time in
Suv39h1 complexes versus 65% in HeLa-Suv39h1 cells (com-
pare Figures 1b and 2b, or see Additional data file 3). Finally,
Suv39h1 is mainly associated with non-modified and dimeth-
ylated forms of H3K36 (Figure 2c).
In the protein complex associated with the HMT G9a,
H3K9me and H3K9me2 both occur 40% of the time (Figure
1b), compared with 21% and 52% in HeLa-G9a cells, respec-
tively (Figure 2c). Thus, there is a significant enrichment of
H3K9nm and H3K9me in the G9a complex. We did not suc-
ceed in detecting H3K9me3 on G9a-associated histone H3,
whereas this modification is detected approximately 13% of
the time in HeLa-G9a cells (Figures 1b and 2b and see Addi-
tional data file 3). G9a protein is associated with the mono-
methylated form of H4K20, with 11% enrichment compared
to the HeLa-G9a cell line. Indeed, G9a is found to be associ-
ated with H4K20me and H4K20me2 37% of the time (Figure
2c). For H3K27 and H3K36, the G9a complex gives the same
distribution as its background cell line. Indeed, G9a is associ-
ated with H3K27me 20% of the time and with H3K27me2
64% of the time. At position H3K36, G9a is found with the
unmodified, mono-, or dimethylated forms (Figure 2c).
In conclusion, a comparison of histone modifications associ-
ated with Suv39h1 or G9a shows that Suv39h1 is associated
with H3K9me3, whereas G9a is associated with H3K9me andhttp://genomebiology.com/2007/8/12/R270 2007,     Volume 8, Issue 12, Article R270       Robin  R270.5
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H3K9me2. This result is expected: Suv39h1 is a known tri-
methylase, and G9a a known dimethylase, of position H3K9.
Surprisingly, Suv39h1 is not associated with H4K20me3.
We have also studied H3 modifications at the following posi-
tions: H3K18, which can be either acetylated or monomethyl-
a t e d ,  t h o u g h  w e  h a v e  a l s o  occasionally detected a
dimethylated form (Additional data file 4); H3K23, which can
only be acetylated; and H3K79, which can be monomethyl-
ated. Surprisingly, we found H3K18ac associated with both
Suv39h1 and G9a complexes 9% of the time (Additional data
file 5). We also detected the monomethylated form of H3K18
in Suv39h1 complexes 8% of the time, constituting an 8%
enrichment, as this modification is barely detectable in HeLa-
Suv39h1 cells. The monomethylated form of H3K18 has been
described previously [27]. Acetylation of H3K23 is present 5%
of the time in Suv39h1 and 8% in G9a complexes (Additional
data file 5). Methylation of H3K79 has also been studied and
was detected in association with Suv39h1 about 15% of the
time, but is not detected with G9a.
Concerning histone H4, we did not find the panacetylated
form of the H4 peptide 4-17 in either Suv39h1 or G9a com-
plexes. However, we found H4K16ac associated with Suv39h1
complexes 17% of the time and with G9a complexes 22% of
the time (Figure 2d). An acetyl group and a trimethyl group
have comparable masses, so to confirm the H4K16ac modifi-
cation, we performed a MALDI-TOF analysis on the same
sample that we used for ion trapping, with internal scaling
using histone peptides of non-ambiguous mass (Additional
data file 6). We found the m/z ratio for the ion to be
1,536.6160. This is in agreement with the theoretical mass of
an acetyl group and four propionyl groups on peptide 4-17.
Thus, the signal detected on H4K16 corresponds most proba-
bly to an acetyl group.
Discussion
Many reports to date have analyzed histone modifications by
different approaches. Although these studies have improved
our understanding of the role of histone modifications in
biological pathways, to our knowledge few studies have
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Post-translational modifications of histones H3 and H4 associated with the  chromatin-binding proteins Suv39h1 and G9a Figure 2
Post-translational modifications of histones H3 and H4 associated with the 
chromatin-binding proteins Suv39h1 and G9a. (a) Schematic 
representation of the purification protocols used to purify the HMT-
histone complexes and crude histones. (b) Doubly immunopurified 
Suv39h1 complexes from chromatin extracts of 20 g of HeLa-Suv39h1 
cells were resolved on a 4-12% gradient NuPAGE gel, run in MES buffer 
(Invitrogen), fixed, and stained with Colloidal blue. Lane 1, SeeBlue pre-
stained molecular weight markers (Invitrogen); lane 2, Suv39h1 complex 
from chromatin fractions. (c) Amino-terminal lysine methylation of 
histones H3 and H4 associated with Suv39h1 or G9a proteins. (d) Post-
translational modifications of histone H4 associated with Suv39h1 or G9a. 
Shown are the means of three independent experiments (± standard 
deviation). 2007, 8:R270
http://genomebiology.com/2007/8/12/R270 2007,     Volume 8, Issue 12, Article R270       Robin  R270.6
sought to provide a systematic analysis of the histone modifi-
cations associated with a given chromatin-binding protein
[30]. In this study, we attempted to investigate modifications
of the histones H3 and H4 associated with the H3K9-specific
HMTs Suv39h1 and G9a.
Basal modifications of histones H3 and H4 in normal 
versus cancer cells
To validate our method, we first studied the basal histone
modifications in the different cell lines used in this study.
H e L a  c e l l s  s t a b l y  e x p r e s s i n g  t a g g e d  H 3 K 9  t r i - m e t h y l a s e
Suv39h1 show an increase in H3K9me3 compared to HeLa
cells, whereas H3K9me and H3K9me2 decrease significantly.
This result is in agreement with a previous work using
suv39h-/- cells in which the level of H3K9me3 was found to
decrease, H3K9me2 was unaffected and H3K9me increased
[24]. Furthermore, a study in Drosophila  showed that a
Suv39h1 hyperactive mutant displayed an increase in H3K9
di- and trimethylation [31]. In HeLa cells expressing tagged
G9a, which is preferentially a dimethylase of H3K9, H3K9me
and H3K9nm increase significantly compared to HeLa cells,
whereas H3K9me2 decreases. This last result was totally
unexpected, but as G9a cooperates with the other EuHMTase,
GLP (EuHMTase 1), it may be necessary to co-express the two
proteins to see an increase in H3K9me2. Taken together,
these results suggest that Suv39h1, when over-expressed, can
convert a mono- or a dimethylated H3K9 to a trimethylated
state, whereas G9a can monomethylate H3K9.
H4K20me3 and H3K27me3 do not seem to change in HeLa-
Suv39h1 compared to HeLa cells. And, generally, H3K27 and
H4K20 methyl modifications are present to the same extent
in HeLa and in HeLa-G9a cells.
We found that three of the repressive methylation modifica-
tions (H3K9me, H3K27me, and H4K20me) were underrepre-
sented in HeLa cells and derivative lines compared to normal
liver cells, whereas the activating modification H3K36me was
overrepresented compared to normal liver cells. The decrease
in repressive methylation is reminiscent of general DNA
methylation in tumor cells [32]. Tumor suppressor gene pro-
moters are found to be heavily methylated in tumors [33,34],
and indeed there is cross-talk between H3K9 methylation and
DNA methylation in many species [21,35,36]. In the case of
tumor suppressor genes, it has been shown that they are also
silenced by methylation on H3K9, H3K27 and H4K20
[33,37], with or without concomitant DNA methylation of the
promoter. Conversely, one might think that oncogenes in
tumor cells could be methylated on H3K36 and hypo-methyl-
a t e d  o n  H 3 K 9  a n d  H 3 K 2 7 .  I t  w i l l  b e  i n t e r e s t i n g  t o  t e s t
whether the methylation pattern of DNA and the methylation
of H3K9 and H3K27 overlap 'geographically' in tumor cells.
Finally, we report here a new modification of histone H4, the
monomethylation of H4K79, which is found at a level of 20%
in normal liver cells, as well as in Hela cells.
Post-translational modifications of Suv39h1- and G9a-
associated histones H3 and H4
We have studied post-translational modifications of chroma-
tin-bound histones associated with the HMTs Suv39h1 and
G9a, which overlap only partially in their nuclear distribu-
tion. Indeed, Suv39h1 is mainly located in the pericentric and
constitutive heterochromatin, whereas G9a was first
described as a euchromatic protein, and later was shown to
have a broader distribution in the nucleus [16]. The distribu-
tion of both proteins is associated with specific methylation
states of Lys9 on histone H3. When associated with Suv39h1
in constitutive heterochromatin, H3K9 is mainly trimethyl-
ated but also dimethylated; when associated with G9a in
euchromatin and facultative heterochromatin, it is either
non-modified, mono-, or dimethylated. We found Suv39h1 to
be associated mainly with dimethylation at H4K20, but G9a
was associated equally frequently with mono- or dimethyla-
tion at this position. Both Suv39h1 and G9a are associated
mainly with the dimethylated form of H3K27.
Thus, Suv39h1 is mainly associated with H3K9me3,
H3K27me2, and H4K20me2. These three modifications are
known to act in concert to create a heterochromatin structure.
At least in embryonic stem cells, Suv39h1 has been suggested
to maintain H3K9 trimethylation, H3K27 monomethylation
and H4K20 trimethylation at pericentromeric heterochroma-
tin [24,38]. The apparent discrepancy between those results
and ours could be explained by differences between embry-
onic stem cells and HeLa cells. Our working model suggests
that there is a direct or indirect interaction between Suv39h1
and the HMTs responsible for H4K20 and H3K27 methyla-
tion, namely Suv4-20h and the Polycomb protein Ezh2,
respectively. Indeed, a physical association between Suv39h1
and PcG proteins has been reported [39].
It has been suggested that H3K9 trimethylation constitutes
the first event leading toward H4K20 trimethylation [38].
HP1 proteins, which recognize H3K9me3 created by Suv39h1,
recruit Suv4-20h, the enzyme that normally establishes
H4K20me3. Our results suggest that Suv39h1 is preferen-
tially associated with H4K20me2, but not H4K20me3. This
association might correspond to an intermediate state of
H4K20 methylation. Another possibility is that heterochro-
matin modification is not homogenous; for example, some
Suv39h1-bound nucleosomes may be dimethylated on
H4K20, while adjacent nucleosomes are trimethylated on
H4K20.
We have found a significant enrichment of H3K18ac and
H3K23ac in Suv39h1-chromatin complexes. H3K23 is
located within the epitope of histone H3 that is recognized by
the chromodomain of Polycomb proteins [19]. Therefore,
H3K23 acetylation could regulate this recognition by prevent-
ing the formation of the Polycomb complex. Indeed, distinct
localizations between H3K9me3, which is associated withhttp://genomebiology.com/2007/8/12/R270 2007,     Volume 8, Issue 12, Article R270       Robin  R270.7
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Suv39h1, and H3K27me3, which is recognized by Polycomb
complex, have been deduced from ChIP-chip analysis [40].
In addition, we have observed an acetylated form of Lys16 of
histone H4 associated with both Suv39h1 and G9a. It is quite
surprising to have H4K16ac associated with the transcription
repressors Suv39h1 and G9a, since this modification is
mainly associated with transcriptional activation. Even so, it
is unclear whether H4K16ac always causes activation, since it
is associated with constitutive heterochromatin in many spe-
cies [41,42], and another acetylation mark, H4K12ac, is
involved in the establishment of heterochromatin in Dro-
sophila [43]. Furthermore, it is known that G9a can be a coac-
tivator [44].
It may be that acetylation at H4K16 is involved in recruiting
Suv39h1 and G9a, but also other proteins, to the histone tails.
For example, the chromatin remodeling complex WINAC has
been described to bind H3K14ac via WSTF to induce repres-
sion of a target gene [45], and H4K16 could play a similar role
in the nucleosomal context. In addition, binding of the NoRC
complex to H4K16ac is required for the subsequent deacetyla-
tion of H4K5, H4K8, and H4K12 during the NoRC-dependent
establishment of heterochromatin [46]. Finally, H4K16
acetylation varies in a cell cycle-dependent manner and is
associated with replication [47-49]. Suv39h1 and G9a are also
linked to DNA replication [50]. As H4K16 is the first lysine to
be acetylated after replication [49], Suv39h1 and G9a could
associate with this form in a replication-dependent manner.
We have found a new histone H4 modification: monomethyl-
ation of H4K79. H4K79me is detected in Suv39h1 and G9a
complexes. This modification has never been described in
mammals but was suggested in Physarum [28]. Mutation of
H4K79 in Saccharomyces cerevisiae affects both telomeric
and rDNA silencing [51]. In fact, H4K79 is part of the Lrs
(Loss of ribosomal silencing) nucleosomal domain [52], sug-
gesting that H4K79 methylation is associated with gene
silencing. Indeed, H4K79 is located close to H3K79 in the
nucleosome structure and contacts the DNA surface [51,53],
suggesting that its charge is important for silencing rDNA
genes [51,53]. Finally, we found H3K79me associated with
Suv39h1, but not with G9a. This modification preferentially
labels constitutive heterochromatin and perhaps more specif-
ically telomeres.
Conclusion
In conclusion, we can combine double immunopurification
and mass spectrometry to uncover novel associations of his-
tone modifications with specific chromatin-binding proteins.
This method allowed us to demonstrate for the first time an
association of acetylated histones with the repressor proteins
Suv39h1 and G9a. It would be interesting to study the signif-
icance of such an association.
Materials and methods
Purification of Suv39h1 and G9a complexes
HeLa cell lines stably expressing Suv39h1 and G9a were
established with human transgenes coding for full-length
proteins Suv39h1 (amino acids 1-412) and G9a (amino acids
1-1,211) tagged with double-HA (haemagglutinin) and dou-
ble-FLAG epitopes at the amino terminus. A HeLa control cell
line transduced with the empty vector has been established
and used to control the complex purification protocols. These
cell lines showed about the same proliferation rate as the par-
ent HeLa cell line.
To purify nucleosomes, we used 20 g of dry cell pellet per
experiment, which corresponds roughly to 10 billion cells.
Cells were resuspended in a hypotonic buffer, lysed and dis-
rupted using 20 strokes of a tight-fitting Dounce homoge-
nizer, and centrifuged to pellet the nuclei [54]. Suv39h1 and
G9a complexes were purified as described in [55]. Briefly,
nuclei were resuspended and digested with micrococcal
nuclease (Sigma, Saint-Quentin Fallavier, France) until they
consisted primarily of mononucleosomes (Additional data
file 1). The complexes associated with nucleosomes were then
purified by immunoprecipitation using anti-FLAG antibody
immobilized on agarose beads (Sigma). After elution with the
FLAG peptide (synthesized by Ansynth, Roosendal, The
Netherlands), the bound complexes containing nucleosomes
were further affinity-purified on anti-HA antibody-conju-
gated agarose (Sigma) and eluted with the HA peptide (syn-
thesized by Ansynth, Roosendal, The Netherlands). The
eluted protein complexes were then resolved on precast
NuPAGE 4-12% bis-Tris acrylamide gradient gel in MES
buffer (Invitrogen, Cergy Pontoise, France) and stained with
Colloidal blue (Invitrogen, Cergy Pontoise, France). At this
step, bands corresponding to histones were cut from the gel
and subjected to a propionylation-based modification
method (see below). The other bands were also cut from the
gel, trypsin-digested using 0.4 mg of sequencing-grade
trypsin (Promega, Charbonnières, France), and identified by
mass spectrometry.
Crude histone purification
Nuclei from mouse liver were prepared as described in [56].
Nuclei from liver cells and nuclei obtained from different
HeLa cell lines were washed, digested with micrococcal
nuclease (Sigma) at 50 units per 20 g of initial tissue or cell
pellet, and sonicated for 4 minutes. Crude nucleosomes were
further purified on a POROS HQ20 anion exchange column
packed in a 4.6 mm × 100 mm POROS column (Applied Bio-
systems, Courtaboeuf, France), loaded at 0.45 M NaCl, and
eluted with a salt gradient extending to 1.5 M NaCl in 50 mM
Tris (pH 6.5).
Nucleosomal histone preparation for mass 
spectrometry analysis
Nucleosomal histones associated with Suv39h1 or G9a, and
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mouse liver, were run on a precast NuPAGE 4-12% bis-Tris
acrylamide gradient gel with MES buffer (Invitrogen, Cergy
Pontoise, France) and stained with Colloidal blue (Invitro-
gen). Gel bands corresponding to each histone were cut and
destained overnight in 50% acetonitrile, 50 mM NH4HCO3.
Histones were then subjected to a propionylation-based mod-
ification method [24-27]. Propionic anhydride makes cova-
lent bonds with non-modified or monomethylated lysines
and with the amino termini of proteins. Gel slices were
treated for 1 h at 37°C with 100 μl of 30% propionic anhydride
in methanol and 40 μl of 50 mM NH4HCO3 [24-26], followed
by two ten-minute washes in 100 mM NH4HCO3, one wash in
50% acetonitrile, 100 mM NH4HCO3, and one wash in ace-
tonitrile. The slices were then dried and digested at 37°C over-
night using 0.4 μg of sequencing-grade trypsin (Promega).
The digests were acidified in 0.5% trifluoroacetic acid, lyophi-
lized, resuspended in 40 μl of 50 mM NH4HCO3, and
propionylated again in 100 μl of 30% propionic anhydride in
methanol for 1 h at 37°C, lyophilized and resuspended in 20
μl of 0.1% of formic acid. The second propionylation modified
the newly created amino-terminal ends after trypsin diges-
tion. These conditions gave complete lysine and amino-termi-
nal propionylation, but also chemical methylations that can
be detected using deuterated methanol (methanol-d4) for the
propionic anhydride dilution (not shown).
Determination of histone modifications by mass 
spectrometry
The peptide mixtures obtained as described above were run
on a Nano C18 PepMap 100 pre-column (5 mm, 100 Å, 300
μm I.D. × 1 mm), coupled with a column of 75 μm I.D. × 15 cm
with the same resin (LC Packings, Dionex, Voisins le Breton-
neux, France). The Nano-flow-High Pressure Liquid Chroma-
tography LC (LC Packings) is directly coupled to an
electrospray ionization system on an ion-trap mass spectrom-
eter (ESI/MS-MS; ThermoFinnigan LCQ Deca XP). The five
most intense ions of the mass spectrometry scan were sub-
jected to fragmentation (MS-MS) without any data-depend-
ent scan. The interpretation of the mass spectrometry data
was performed with the BioWorks software version 3.2
(Thermo Scientific, Courtaboeuf, France), with the following
specifications: a bank of peptides from the histones cut at
arginine residues was indexed with permanent add mass for
the amino terminus and lysine of 56.025 Da, and three poten-
tial modifications - K minus 14.015 for acetylation or trimeth-
ylation, K+14.015 Da for a monomethylation and K minus
27.995 Da for a dimethylation. This set-up allowed us to auto-
mate analysis of the mass spectrometry raw data. Each raw
dataset was analyzed to check for combinations of modifica-
tions that might have been missed by the automated method.
We also took advantage of the fact that each modification
shows a specific retention time on reverse phase HPLC. Ions
di- and trimethylated on lysine elute before acetylated ones,
propionylated ones elute later, and propionylated plus mono-
methylated elute last. Just one ion did not follow this rule,
namely, the highly hydrophobic peptide that bears the H4K79
amino acid, for which the propionylated and methylated form
elutes before the propionylated one. Retention times were
used to confirm that the data analysis reconstituted the frag-
mentation correctly. Histone modifications were quantified
by the number of ions detected by MS/MS analysis: for each
post-translational modification, results are presented as the
number of ions detected that bear the modification,
expressed as a percentage of the total number of peptides
(modified or not) recognized in the MS/MS analysis. All
masses are expressed in centroid m/z values.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 shows the size of
the DNA extracted from the nucleosomal preparation used to
purify the Suv39h1 complex. Additional data file 2 shows the
fragmentation of the ion H4K79me. Additional data file 3
shows selected amino-terminal lysine methylations of the his-
tones H3 and H4 associated with Suv39h1 and G9a proteins
compared to their background cell lines. Additional data file
4 is about the fragmentation of the 1,027 m/z ion with a pro-
pionyl group at the amino terminus, two methyl groups on
lysine H3K18, and a propionyl group on H3K23. Additional
data 5 shows selected histone H3 modifications in different
cell backgrounds and in Suv39h1 and G9a complexes. Addi-
tional data 6 shows the H4K16ac fragmentation on a MALDI-
TOF.
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 2007, 8:R270
Acknowledgements
We thank Drs Thomas Jenuwein, Yoichi Shinkai, Irina Stancheva, Didier
Trouche, Annick Harel-Bellan, Ali Hamiche and Marie Körner for providing
crucial reagents. We thank Dr Anna Polesskaya, Mouloud Souidi, Dr Khalid
Ouararhni and Maxime Marouteau for sharing material and technical help.
We thank Drs Linda L Pritchard, Anna Polesskaya, Valentina Guasconi and
Maya Ameyar-Zazoua for critical reading of the manuscript and scientific
discussions. This work was supported by the Association Française contre
les Myopathies (AFM); the Fondation Bettencourt-Schueller; the Ligue
Nationale contre le Cancer (LNCC); the Association pour la Recherche sur
le Cancer (ARC); the Ministère de la Recherche (ACI-Jeunes chercheurs,
décision N° 04 3 75), the CNRS; and the Université Paris-Sud Orsay. OP
was recipient of fellowship from the Ministère de la Recherche.
References
1. Kouzarides T: Chromatin modifications and their function.
Cell 2007, 128:693-705.
2. Martin C, Zhang Y: The diverse functions of histone lysine
methylation.  Nat Rev Mol Cell Biol 6:
The epigenetic magic of histone lysine
methylation. FEBS J 273:
Histone lysine methylation:
a signature for chromatin function. Trends Genet
19:
The Set2 his-
tone methyltransferase functions through the phosphor-
ylated carboxyl-terminal domain of RNA polymerase II. J Biol
Chem 278:
 et al. Set2 is a nucleosomal
histone H3-selective methyltransferase that mediates tran-
scriptional repression. Mol Cell Biol 22:
Trilogies of histone
lysine methylation as epigenetic landmarks of the eukaryotic
genome. Cold Spring Harb Symp Quant Biol 69:
Active genes are
tri-methylated at K4 of histone H3. Nature 419:
Unsafe SETs: histone
lysine methyltransferases and cancer. Trends Biochem Sci
27:
Mitotic phospho-
rylation of SUV39H1, a novel component of active centro-
meres, coincides with transient accumulation at mammalian
centromeres. J Cell Sci 113:
 et al. Functional mamma-
lian homologues of the Drosophila PEV-modifier Su(var)3-9
encode centromere-associated proteins which complex with
the heterochromatin component M31. EMBO J
18:
Structure-function analysis of SUV39H1 reveals a dominant
role in heterochromatin organization, chromosome segre-
gation, and mitotic progression. Mol Cell Biol
20:
 et al. Isolation and
characterization of Suv39h2, a second histone H3 methyl-
transferase gene that displays testis-specific expression. Mol
Cell Biol 20:
Set domain-con-
taining protein, G9a, is a novel lysine-preferring mammalian
histone methyltransferase with hyperactivity and specific
selectivity to lysines 9 and 27 of histone H3. J Biol Chem
276:
 et al. G9a histone methyltrans-
ferase plays a dominant role in euchromatic histone H3
lysine 9 methylation and is essential for early embryogenesis.
Genes Dev 16:
Functional analysis of the N- and C-terminus of mammalian
G9a histone H3 methyltransferase. Nucleic Acids Res
33:
Kim J, Daniel J, Espejo A, Lake A, Krishna M, Xia L, Zhang Y, Bedford
MT: Tudor, MBT and chromo domains gauge the degree of
lysine methylation.  EMBO Rep 2006, 7:397-403.
18. Shi X, Kachirskaia I, Walter KL, Kuo JH, Lake A, Davrazou F, Chan
SM, Martin DG, Fingerman IM, Briggs SD, et al.: Proteome-wide
analysis in Saccharomyces cerevisiae identifies several PHD
fingers as novel direct and selective binding modules of his-
tone H3 methylated at either lysine 4 or lysine 36.  J Biol Chem
2007, 282:2450-2455.
19. Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S:
Molecular basis for the discrimination of repressive methyl-
lysine marks in histone H3 by Polycomb and HP1
chromodomains.  Genes Dev 2003, 17:1870-1881.
20. Tamaru H, Selker EU: A histone H3 methyltransferase controls
DNA methylation in Neurospora crassa.  Nature 2001,
414:277-283.
21. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T: The
methyl-CpG-binding protein MeCP2 links DNA methylation
to histone methylation.  J Biol Chem 2003, 278:4035-4040.
22. Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD, Spector DL:
Methylation of histone H3 at Lys-9 is an early mark on the X
chromosome during X inactivation.  Cell 2001, 107:727-738.
23. Strahl BD, Allis CD: The language of covalent histone
modifications.  Nature 2000, 403:41-45.
24. Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-
Burgos L, Kohlmaier A, Opravil S, Tachibana M, Shinkai Y, et al.: Par-
titioning and plasticity of repressive histone methylation
states in mammalian chromatin.  Mol Cell 2003, 12:1577-1589.
25. Johnson L, Mollah S, Garcia BA, Muratore TL, Shabanowitz J, Hunt
DF, Jacobsen SE: Mass spectrometry analysis of Arabidopsis his-
tone H3 reveals distinct combinations of post-translational
modifications.  Nucleic Acids Res 2004, 32:6511-6518.
26. Bonaldi T, Imhof A, Regula JT: A combination of different mass
spectroscopic techniques for the analysis of dynamic changes
of histone modifications.  Proteomics 2004, 4:1382-1396.
27. Garcia BA, Hake SB, Diaz RL, Kauer M, Morris SA, Recht J, Shabanow-
itz J, Mishra N, Strahl BD, Allis CD, et al.: Organismal differences
in post-translational modifications in histones H3 and H4.  J
Biol Chem 2007, 282:7641-7655.
28. Waterborg JH, Fried SR, Matthews HR: Acetylation and methyla-
tion sites in histone H4 from Physarum polycephalum.  Eur J
Biochem 1983, 136:245-252.
29. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J,
Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, et al.: Loss of
acetylation at Lys16 and trimethylation at Lys20 of histone
H4 is a common hallmark of human cancer.  Nat Genet 2005,
37:391-400.
30. Zhou H, Madden BJ, Muddiman DC, Zhang Z: Chromatin assem-
bly factor 1 interacts with histone H3 methylated at lysine 79
in the processes of epigenetic silencing and DNA repair.  Bio-
chemistry 2006, 45:2852-2861.
31. Ebert A, Schotta G, Lein S, Kubicek S, Krauss V, Jenuwein T, Reuter
G: Su(var) genes regulate the balance between euchromatin
and heterochromatin in Drosophila.  Genes Dev 2004,
18:2973-2983.
32. Robertson KD: DNA methylation and human disease.  Nat Rev
Genet 2005, 6:597-610.
33. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC,
Liang G, Jones PA: Histone H3-lysine 9 methylation is associ-
ated with aberrant gene silencing in cancer cells and is rap-
idly reversed by 5-aza-2'-deoxycytidine.  Cancer Res 2002,
62:6456-6461.
34. Kondo Y, Shen L, Issa JP: Critical role of histone methylation in
tumor suppressor gene silencing in colorectal cancer.  Mol
Cell Biol 2003, 23:206-215.
35. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L,
Kubicek S, Chen T, Li E, Jenuwein T, Peters AH: Suv39h-mediated
histone H3 lysine 9 methylation directs DNA methylation to
major satellite repeats at pericentric heterochromatin.  Curr
Biol 2003, 13:1192-1200.
36. Tariq M, Saze H, Probst AV, Lichota J, Habu Y, Paszkowski J: Erasure
of CpG methylation in Arabidopsis alters patterns of histone
H3 methylation in heterochromatin.  Proc Natl Acad Sci USA
2003, 100:8823-8827.
37. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin
SB: Silenced tumor suppressor genes reactivated by DNA
demethylation do not return to a fully euchromatic chroma-
tin state.  Cancer Res 2006, 66:3541-3549.Genome Biology 2007, 8:R270
http://genomebiology.com/2007/8/12/R270 Genome Biology 2007,     Volume 8, Issue 12, Article R270       Robin et al. R270.10
38. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Rein-
berg D, Jenuwein T: A silencing pathway to induce H3-K9 and
H4-K20 trimethylation at constitutive heterochromatin.
Genes Dev 2004, 18:1251-1262.
39. Sewalt RG, Lachner M, Vargas M, Hamer KM, den Blaauwen JL, Hen-
drix T, Melcher M, Schweizer D, Jenuwein T, Otte AP: Selective
interactions between vertebrate polycomb homologs and
the SUV39H1 histone lysine methyltransferase suggest that
histone H3-K9 methylation contributes to chromosomal tar-
geting of Polycomb group proteins.  Mol Cell Biol 2002,
22:5539-5553.
40. O'Geen H, Squazzo SL, Iyengar S, Blahnik K, Rinn JL, Chang HY,
Green R, Farnham PJ: Genome-wide analysis of KAP1 binding
suggests autoregulation of KRAB-ZNFs.  PLoS Genet 2007,
3:e89.
41. Belyaev ND, Keohane AM, Turner BM: Histone H4 acetylation
and replication timing in Chinese hamster chromosomes.
Exp Cell Res 1996, 225:277-285.
42. Belyaev ND, Houben A, Baranczewski P, Schubert I: The acetyla-
tion patterns of histones H3 and H4 along Vicia faba chromo-
somes are different.  Chromosome Res 1998, 6:59-63.
43. Swaminathan J, Baxter EM, Corces VG: The role of histone H2Av
variant replacement and histone H4 acetylation in the estab-
lishment of Drosophila  heterochromatin.  Genes Dev 2005,
19:65-76.
44. Lee DY, Northrop JP, Kuo MH, Stallcup MR: Histone H3 lysine 9
methyltransferase G9a is a transcriptional coactivator for
nuclear receptors.  J Biol Chem 2006, 281:8476-8485.
45. Fujiki R, Kim MS, Sasaki Y, Yoshimura K, Kitagawa H, Kato S: Ligand-
induced transrepression by VDR through association of
WSTF with acetylated histones.  EMBO J 2005, 24:3881-3894.
46. Zhou Y, Grummt I: The PHD finger/bromodomain of NoRC
interacts with acetylated histone H4K16 and is sufficient for
rDNA silencing.  Curr Biol 2005, 15:1434-1438.
47. Turner BM: Histone acetylation and control of gene
expression.  J Cell Sci 1991, 99:13-20.
48. Belyaev ND, Houben A, Baranczewski P, Schubert I: Histone H4
acetylation in plant heterochromatin is altered during the
cell cycle.  Chromosoma 1997, 106:193-197.
49. Waterborg JH: Identification of five sites of acetylation in
alfalfa histone H4.  Biochemistry 1992, 31:6211-6219.
50. Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf
AR, Carey MF, Pradhan S: Direct interaction between DNMT1
and G9a coordinates DNA and histone methylation during
replication.  Genes Dev 2006, 20:3089-3103.
51. Hyland EM, Cosgrove MS, Molina H, Wang D, Pandey A, Cottee RJ,
Boeke JD: Insights into the role of histone H3 and histone H4
core modifiable residues in Saccharomyces cerevisiae.  Mol Cell
Biol 2005, 25:10060-10070.
52. Fry CJ, Norris A, Cosgrove M, Boeke JD, Peterson CL: The LRS and
SIN domains: two structurally equivalent but functionally
distinct nucleosomal surfaces required for transcriptional
silencing.  Mol Cell Biol 2006, 26:9045-9059.
53. Mersfelder EL, Parthun MR: The tale beyond the tail: histone
core domain modifications and the regulation of chromatin
structure.  Nucleic Acids Res 2006, 34:2653-2662.
54. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription ini-
tiation by RNA polymerase II in a soluble extract from iso-
lated mammalian nuclei.  Nucleic Acids Res 1983, 11:1475-1489.
55. Ouararhni K, Hadj-Slimane R, Ait-Si-Ali S, Robin P, Mietton F, Harel-
Bellan A, Dimitrov S, Hamiche A: The histone variant mH2A1.1
interferes with transcription by down-regulating PARP-1
enzymatic activity.  Genes Dev 2006, 20:3324-3336.
56. Blobel G, Potter VR: Nuclei from rat liver: isolation method
that combines purity with high yield.  Science 1966,
154:1662-1665.